SCOT Registry: Small Cell Lung Cancer Treatment and Outcome

The registry is an international, multicenter, observational registry of newly diagnosed patients with SCLC.

Data will be entered into an electronic CRF (eCRF) via Internet access. Treatment plan remains the responsibility of the patient's physician and data collected in this registry will reflect a "real world" approach of the diagnosis and treatment of patients with SCLC.

Approximately 60 centres in 13 countries will take part in this registry. It is expected that about 500 patients will be recruited during a period of 6 to 9 months according to the feasibility.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lung Cancer, Small Cell Bronchial Neoplasms Carcinoma, Bronchogenic Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Small Cell Lung Carcinoma Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

GSK Investigational Site, Graz, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or Female >/= 18 years
Diagnosis of small cell lung cancer
Patient newly diagnosed with SCLC
Has given written informed consent (if applicable)

Exclusion criteria

Concurrent history of other neoplasm, except curatively treated basal cell skin cancer or adequately treated in-situ carcinoma of the cervix.
Patient presenting with recurrence of SCLC.
Patients who has received any chemotherapy for the SCLC.

Treatment and study plan

Hycamtin

Drug

Observing patients on HYCAMTIN and other drugs for SCLC.

Primary outcomes

Registry with disease, treatment and outcome data collected.

Time frame: 6-9mth recruitment period, 18mth study duration.

Secondary outcomes

survival rates

Time frame: 18 month period

Sponsors and collaborators

Lead sponsor

GlaxoSmithKline

Industry

Registry information

Acronym: SCOT

Important dates

Study start: 2009
Primary completion: 2012
Study completion: 2012
First posted: Oct 16, 2009
Registry last updated: Feb 3, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed